87 related articles for article (PubMed ID: 6126367)
1. Ascorbate injury and EDTA (or manganese) protection of D2-dopamine receptors.
Chan B; Seeman P; Davis A; Madras BK
Eur J Pharmacol; 1982 Jun; 81(1):111-6. PubMed ID: 6126367
[TBL] [Abstract][Full Text] [Related]
2. Effects of heavy metal cations, sulfhydryl reagents and other chemical agents on striatal D2 dopamine receptors.
Scheuhammer AM; Cherian MG
Biochem Pharmacol; 1985 Oct; 34(19):3405-13. PubMed ID: 3931643
[TBL] [Abstract][Full Text] [Related]
3. Modulation of dopamine receptor binding by ascorbic acid.
Madras BK; Chan B
Adv Biochem Psychopharmacol; 1983; 37():275-87. PubMed ID: 6138950
[No Abstract] [Full Text] [Related]
4. Solubilization of neuroleptic/dopamine receptors of human brain striatum.
Davis A; Madras B; Seeman P
Eur J Pharmacol; 1981 Mar; 70(3):321-9. PubMed ID: 6112153
[TBL] [Abstract][Full Text] [Related]
5. Solubilized dopamine/neuroleptic receptors (D2-type).
Madras BK; Davis A; Chan B; Seeman P
Prog Neuropsychopharmacol; 1981; 5(5-6):543-8. PubMed ID: 6122229
[No Abstract] [Full Text] [Related]
6. Differential effects of ascorbate and EDTA on high-affinity binding of 3H-apomorphine and 3H-ADTN to calf caudate membranes.
Arana GW; Baldessarini RJ; Kula NS
Neuropharmacology; 1982 Jun; 21(6):601-4. PubMed ID: 6810198
[TBL] [Abstract][Full Text] [Related]
7. Ascorbic acid reduces accumulation of [3H]spiperone in mouse striatum in vivo.
Dorris RL
Proc Soc Exp Biol Med; 1987 Oct; 186(1):13-6. PubMed ID: 3628250
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibitory effects of ascorbic acid on the binding of dopamine agonists and antagonists to neostriatal membrane preparations: correlations with behavioral effects.
Heikkila RE; Cabbat FS; Manzino L
Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):409-21. PubMed ID: 7323442
[TBL] [Abstract][Full Text] [Related]
9. Studies on the stability of 3H-dopamine, 3H-apomorphine and 3H-ADTN: effects of sodium ascorbate and EDTA.
Cabbat FS; Manzino L; Heikkila RE
Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):333-43. PubMed ID: 3922020
[TBL] [Abstract][Full Text] [Related]
10. Antioxidants prevent the interaction of 3,4-dihydroxyphenylacetic acid at the dopamine D2 receptor.
Cammack J; Tessel R; Michaelis E; Adams RN
Eur J Pharmacol; 1991 Aug; 201(1):111-3. PubMed ID: 1838982
[TBL] [Abstract][Full Text] [Related]
11. The use of ascorbate as a probe of opioid receptor structure: evidence for two independent mechanisms of receptor destruction by ascorbate.
Cox BM; Leslie FM; Dunlap CE
J Recept Res; 1980; 1(2):329-54. PubMed ID: 6271956
[TBL] [Abstract][Full Text] [Related]
12. Ascorbate induced lipid peroxidation results in loss of receptor binding in tris, but not in phosphate, buffer. Implications for the involvement of metal ions.
Abe K; Kogure K; Arai H; Nakano M
Biochem Int; 1985 Sep; 11(3):341-8. PubMed ID: 3933512
[TBL] [Abstract][Full Text] [Related]
13. Dual effects of ascorbate on serotonin and spiperone binding in rat cortical membranes.
Muakkassah-Kelly SF; Andresen JW; Shih JC; Hochstein P
J Neurochem; 1983 Nov; 41(5):1429-39. PubMed ID: 6413657
[TBL] [Abstract][Full Text] [Related]
14. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
O'Boyle KM; Waddington JL
Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
[TBL] [Abstract][Full Text] [Related]
15. Ascorbic acid and membrane ageing: critical determinants of the in-vitro binding of [3H]ADTN to rat striatal tissue.
Bradbury AJ; Costall B; Naylor RJ
J Pharm Pharmacol; 1983 Nov; 35(11):738-45. PubMed ID: 6139456
[TBL] [Abstract][Full Text] [Related]
16. Blockade of both D1- and D2-dopamine receptors inhibits amphetamine-induced ascorbate release in the neostriatum.
Oh C; Gardiner TW; Rebec GV
Brain Res; 1989 Feb; 480(1-2):184-9. PubMed ID: 2565749
[TBL] [Abstract][Full Text] [Related]
17. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
18. Dopamine receptors labelled by [3H]quinpirole.
Seeman P; Schaus JM
Eur J Pharmacol; 1991 Oct; 203(1):105-9. PubMed ID: 1686763
[TBL] [Abstract][Full Text] [Related]
19. Dopamine receptors in rat brain regions. Optimal conditions for 3H-agonist binding, pH dependency and lack of inhibition by ascorbic acid.
Bacopoulos NG
Biochem Pharmacol; 1982 Oct; 31(19):3085-91. PubMed ID: 7150335
[TBL] [Abstract][Full Text] [Related]
20. Comparison of soluble dopamine D2-receptors from three species.
Madras BK; Davis A; Seeman P
Eur J Pharmacol; 1982 Mar; 78(4):431-8. PubMed ID: 7075677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
